secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001658247-26-000017
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics Pharmaceuticals dismisses auditor BDO, appoints PwC
-------------------------------------------------------------

- Audit Committee dismissed BDO on Feb 27, 2026; no disagreements or reportable events for FY2024/2025.
- BDO's reports on FY2024 and FY2025 financial statements were unqualified.
- PwC appointed as new independent auditor for the fiscal year ending Dec 31, 2026.
- No consultations with PwC prior to appointment regarding accounting principles or audit opinions.
- BDO provided a letter to the SEC agreeing with the disclosures, attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000165824726000017/0001658247-26-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000165824726000017/crnx-20260227.htm
  HTML page:      https://secwatch.observer/filing/0001658247-26-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer